Clinical Trial Update: AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating the AeriSeal System for lung volume reduction in advanced emphysema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• AeriSeal System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema, COPD | Phase 2, Phase 3 | Status: COMPLETED